Secondary prevention after myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications* / Q000188:drug therapy / Q000534:rehabilitation; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D011379:Prognosis; D011433:Propranolol / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D013999:Timolol; D011433:Propranolol; D008790:Metoprolol